Research area
Lung Cancer surgery and procedure trials
You will find lung cancer studies listed here, and each one tests a surgery or another procedure. Cancer Surgery Trials can help you learn whether a study may be a fit for you.
Updated
- No cost to ask
- Taking part is voluntary
- Studies are independently reviewed
Lung cancer surgery and procedure studies in numbers
- lung cancer surgery and procedure studies recruiting in the U.S.
- 117
- states with a study site
- 51
- studies that accept healthy volunteers
- 9
Source: ClinicalTrials.gov. Data processed .
Find lung cancer surgery and procedure studies by state
These states have the most studies recruiting right now.
California
34 studies recruiting.
Ohio
31 studies recruiting.
Illinois
26 studies recruiting.
New York
25 studies recruiting.
Pennsylvania
24 studies recruiting.
Texas
22 studies recruiting.
Lung cancer surgery and procedure studies recruiting now
As of November 18, 2026, 117 lung cancer surgery and procedure studies are recruiting participants in the United States, according to ClinicalTrials.gov. This site lists only studies that test a surgery or another procedure, as each study is coded in the registry. This is what they have in common.
What they test
- procedures117
- other approaches54
- medications52
- biologics such as vaccines or antibodies36
- radiation22
A study can test more than one.
Main purpose
- treating a condition72
- supportive care12
- diagnosis6
- prevention4
Phase
- Early Phase 11
- Phase 116
- Phase 1/29
- Phase 233
- Phase 2/31
- Phase 310
- Phase 42
- No phase27
- Observational18
Studies of devices and behavioral approaches have no phase.
Who runs them
- university, hospital or other102
- government13
- industry2
Who they enroll
- adults (18 to 64)116
- older adults (65 and over)115
9 also accept healthy volunteers.
These counts come from each study's public record and change as studies open and close. Browse every location to see what is recruiting near you.
Source: ClinicalTrials.gov. Data processed . Each bar shows a count as a share of all 117 studies.
Recently updated lung cancer surgery and procedure studies
The 6 studies whose public records changed most recently, with some of the places each is recruiting. Select a study to read its full record on ClinicalTrials.gov.
Testing Lutetium Lu 177 Dotatate in Patients With Somatostatin Receptor Positive Advanced Bronchial Neuroendocrine Tumors
- Phase 2
- Ages 18 and older
- All sexes
- Sponsor
- National Cancer Institute (NCI)
- Recruiting in
- Ankeny, IA · Beverly Hills, CA · Boston, MA · and 18 more U.S. locations
- Registry record
- NCT04665739 · updated
Immunotherapy After Surgery for People Who Have No Remaining Cancer Cells After Standard Treatment for Early-Stage Non-Small Cell Lung Cancer, INSIGHT Trial
- Phase 3
- Ages 18 and older
- All sexes
- Sponsor
- National Cancer Institute (NCI)
- Recruiting in
- ‘Aiea, HI · ‘Ewa Beach, HI · Aberdeen, MD · and 223 more U.S. locations
- Registry record
- NCT06498635 · updated
Testing the Impact of an Anti-Cancer Drug, Atezolizumab, After Surgery to Prevent Early Stage Non-small Cell Lung Cancer From Returning, AASI-NSCLC Trial
- Phase 3
- Ages 18 and older
- All sexes
- Sponsor
- National Cancer Institute (NCI)
- Recruiting in
- Ames, IA · Anaconda, MT · Anaheim, CA · and 124 more U.S. locations
- Registry record
- NCT07388524 · updated
JoLT-Ca Sublobar Resection (SR) Versus Stereotactic Ablative Radiotherapy (SAbR) for Lung Cancer
- Phase 3
- Ages 18 and older
- All sexes
- Sponsor
- University of Texas Southwestern Medical Center
- Recruiting in
- Dallas, TX · Neptune City, NJ · Pittsburgh, PA · and 2 more U.S. locations
- Registry record
- NCT02468024 · updated
Testing the Combination of an Anti-cancer Drug, Iadademstat, With Other Anti-cancer Drugs (Atezolizumab or Durvalumab) at Improving Outcomes for Small Cell Lung Cancer
- Phase 1/2
- Ages 18 and older
- All sexes
- Sponsor
- National Cancer Institute (NCI)
- Recruiting in
- Atlanta, GA · Baltimore, MD · Charlotte, NC · and 28 more U.S. locations
- Registry record
- NCT06287775 · updated
Pembrolizumab in Combination With Chemotherapy and Image-Guided Surgery for Malignant Pleural Mesothelioma (MPM)
- Phase 1
- Ages 18 and older
- All sexes
- Sponsor
- Abramson Cancer Center at Penn Medicine
- Recruiting in
- Philadelphia, PA
- Registry record
- NCT03760575 · updated
Source: ClinicalTrials.gov. Data processed . See every lung cancer study recruiting in the United States on ClinicalTrials.gov.
About these listings
These listings come from ClinicalTrials.gov, the study registry run by the U.S. National Library of Medicine. The data were processed on November 18, 2026. We show part of each public record (its title, phase, sponsor, basic eligibility and some of the places it is recruiting) exactly as registered. Nothing in a record is reworded. This site lists only studies that test a surgery or another procedure, as each study is coded in the registry.
Cancer Surgery Trials does not run these studies and is not affiliated with their sponsors. A listing is not a recommendation, and only a study's own team can tell you whether you may be eligible. Follow the link on any study to read its full record and contact that team directly, or ask us and a coordinator will help you understand your options. How we source and check what we publish.
What lung cancer surgery and procedure studies look at
When you open a listing here, you will find a lung cancer study that tests a surgery or another procedure. Each one is set up to answer a single question of its own. For that reason, the things you would be asked to do change from one study to the next.
The surgery or procedure being tested is investigational in every case. How well it works, and which risks come with it, are things researchers have not finished learning. The study is run to find that out.
Who may be able to take part
Before you can join, a study will measure you against its own set of requirements. These may cover the medicines you take now, your health history, your age, and how lung cancer affects you. There are also studies open to people without lung cancer.
Deciding whether you are eligible is not your job. That check happens at a screening visit, and the study team carries it out. Read how screening and eligibility are handled.
What taking part usually involves
A first conversation
First, a coordinator talks you through the study in general terms. Your questions are answered before anything else takes place.
Informed consent
You will be handed the complete details of the lung cancer surgery or procedure trial in writing, with the known risks listed among them. These come from the study team. Agreeing or not is then up to you.
Screening
Screening comes next. Through questions about your health and some tests, it becomes clear whether the surgery or procedure trial suits you. Being screened does not always lead to taking part, and some people go no further than this step.
Study visits
Should you join, scheduled visits follow, and you attend each one so that your health can be followed by the people running the trial. Leaving the study is possible at any time.
Questions about lung cancer surgery and procedure studies
Do I need a diagnosis to join a study about lung cancer?
You will find out from the study team what is required in your case, because it varies from one lung cancer surgery or procedure trial to the next. A confirmed diagnosis is asked for in some. In others, the assessment happens while you are being screened.
Would I have to change the care I receive now?
The study doctor will go over your current care with you, so please do not change anything on your own. In some studies current care can continue, and in others it cannot. Before you decide, you are welcome to talk it over with your own doctor.
Is there a cost to take part?
Participants generally pay nothing for the visits and tests a study requires, or for the surgery or procedure it is testing. Find out more about costs.
Ask about lung cancer surgery and procedure studies
A coordinator will contact you once Cancer Surgery Trials has a little information from you. Sharing it is only an enquiry about lung cancer surgery and procedure trials. It commits you to nothing.
Independent information
- Lung Cancer — National Cancer Institute (NIH)
- What Are Clinical Trials? — National Cancer Institute (NIH)
- ClinicalTrials.gov study registry — ClinicalTrials.gov (National Library of Medicine)